Kazi Tasneem is a Preclinical Senior Scientist at Genentech Inc., specializing in antibody drug development with over 3 years of industry experience. She focuses on computational prediction models for drug transport in preclinical settings, overseeing the design/strategy and interpretation of pharmacokinetics/pharmacodynamics studies for antibody/biologics in cancer immunotherapy. She holds a PhD in Chemical Engineering from Vanderbilt University, a Master’s degree in Materials Science and Engineering from the University of Central Florida and a Master’s degree in Environmental Engineering from Carnegie Mellon University. She completed her Bachelor’s degree in Chemical Engineering from Bangladesh University of Engineering and Technology (BUET). Kazi is an Advisory Council Member of the Engineering Leadership Program at California State University, Chico. She has received prestigious awards, including the Best Abstract Award for biological modeling from the Society of Toxico